1[1]Tanner CM, Langston JW.Do environmental toxins cause Parkinson' s disease?A critical review[J ]. Neurology, 1990, 40:17
2[2]Przedborski S, Jackson - Lewis V. Role of neuronal nitric oxide in 1- methyl- 4- phenyl 1, 2, 3, 6- tetrahydropyridine(MPTP) induced dopaminergic neurotoxicity[J] . Proc Natl Acad Sci USA, 1996, 93:4565
3[3]Polymeropoulos MH, Lavedan C. Mutation in the α - Synuclein gene identified in falimilies with Parkinsons' disease [J] . Science, 1997, 76:2045
4[4]Jenner P, Olanow CW. Oxidative stress and the pathogenesis ofParkinson's disease[J]. Neurology, 1996, 47:161
5[5]Connor JR, Snyder BS. Quantitative analysis of isoferritins in select regions of aged, Parkinsonian, and Alzheimer diseased brains[ J ]. J Neurochem, 1995, 65: 717
6[6]Pearce R, Owen A. Alterations in the distribution of glutathione in the substantia nigra in Parkinson' s disease[J] .J Neural Transm, 1997, 104: 661
7[7]Alam ZI. Jenner A. Oxidative DNA damage in the parkinsonian brain: a selective increase in 8 hydroxyguanine in substantia nigra[J] .J Neurochem, 1997, 69:1196
8[8]Schapira AHV, Copper JM. Mitochondrial compl I deficiency in Parkinson' s disease [J ]. J Neurochem, 1990, 54: 823
9[9]Macaya A, Munell F.Apoptosis in substantia nigra following developmental striatal excitotoxic injury[J ]. Proc Natl Acad Sci USA, 1994, 91: 8117
10[10]Chadi G, Cao Y. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6 - hydroxydopamine induced degeneration of the nigrostriatal dopamine neurons[ J ]. Neuroscience, 1994, 61: 891
